Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy.

AuthorsJ E Mangino, R J Fass
JournalLancet (London, England) (Lancet) Vol. 350 Issue 9071 Pg. 150 (Jul 12 1997) ISSN: 0140-6736 [Print] ENGLAND
PMID9228998 (Publication Type: Letter, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antiviral Agents
  • Placebos
  • Zidovudine
  • Abnormalities, Drug-Induced (etiology)
  • Acquired Immunodeficiency Syndrome (congenital, drug therapy, transmission)
  • Antiviral Agents (therapeutic use)
  • Clinical Trials as Topic
  • Female
  • Fetal Diseases (chemically induced)
  • HIV Infections (congenital, drug therapy, transmission)
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Placebos
  • Pregnancy
  • Pregnancy Complications, Infectious (drug therapy)
  • Pregnant Women
  • Risk
  • Risk Assessment
  • Risk Factors
  • Therapeutic Human Experimentation
  • Women's Health
  • Zidovudine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: